Manufacturing, Monoclonal Antibodies

Lonza Launches New Cell Line for Higher Potency Antibody Development

November 16, 2023

Lonza’s new GS Effex cell line can help overcome the challenges of developing therapeutic antibodies with increased potency.

Aragen to Establish $30 Million Biomanufacturing Facility in India

November 02, 2023

As part of a $30 million investment, Aragen is setting up a new biologics manufacturing facility in Bangalore, India.

Optimization of Linker Chemistries for Antibody-Drug Conjugates

November 02, 2023

There is no such thing as a perfect linker.

Remembering Raw Material Basics for mAb Production

November 02, 2023

Re-evaluating the basics of mAb production may be beneficial for the biopharma industry as a whole.

Image Analysis Algorithm for Therapeutic mAb Aggregate Analysis

September 02, 2023

Image analysis algorithms coupled with microscopy techniques can be used to characterize aggregates of therapeutic proteins.

Pushing Forward in Next-Gen Antibody Development

July 12, 2023

Exploring new fields can bring novel antibody candidates to the pipeline.

Chime Biologics Forms mAb Development and Manufacturing Deal with Leads Biolabs and BeiGene

July 06, 2023

Chime Biologics, Leads Biolabs, and BeiGene have formed a three-way collaboration to advance the development and global manufacturing of Leads Biolabs’ lead mAb candidate, LBL-007.

Small-Scale Syringe and Vial-Filling Capability for Development of Robust Filling Processes, Smooth Tech Transfers, and to Resolve Manufacturing Issues: Summary of Key Learnings

July 02, 2023

Use of a small-scale filler can result in increased filling efficiency.

Pushing the Barriers in Next-Gen Antibody Development

June 02, 2023

New fields are being explored to bring novel antibody candidates to the pipeline.

Pulling Out All the Stops in mAb Manufacturing

June 02, 2023

Compliance with GMP standards remains an integral focus in bulk mAb manufacturing.